1 documents found
Information × Registration Number 0118U004351, R & D request Title A randomized, double-blind, placebo-controlled Phase II study of the M2951 drug with a parallel active control group (Tecfider drug) in open-label patients in patients with recurrent multiple sclerosis to evaluate efficacy, safety, tolerability, pharmacokinetics and biological activity Head Lytvynenko Nataliia , Доктор медичних наук Registration Date 19-04-2018 Organization Ukrainian medical stomatological Academy popup.description1 popup.nrat_date 2024-12-10 Close
search.res_rk
A randomized, double-blind, placebo-controlled Phase II study of the M2951 drug with a parallel active control group (Tecfider drug) in open-label patients in patients with recurrent multiple sclerosis to evaluate efficacy, safety, tolerability, pharmacokinetics and biological activity
Head: Lytvynenko Nataliia . A randomized, double-blind, placebo-controlled Phase II study of the M2951 drug with a parallel active control group (Tecfider drug) in open-label patients in patients with recurrent multiple sclerosis to evaluate efficacy, safety, tolerability, pharmacokinetics and biological activity. Ukrainian medical stomatological Academy. № 0118U004351
1 documents found

Updated: 2026-03-23


Роздрукувати цю сторінку